INNATE PHARMA: cashflow_investing
| Value | {"amount": -62121000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T01:52:01.406755+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/f2ed9a74-4d79-4d33-8870-5667ed458de3
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2020-12-31Retrieved: 2026-08-24T01:52:01.406755+02:00
Raw response sha256:
354f3f3237e82bfb1dcf2f5d47f77cbb…Cite as: FACTANKER, https://factanker.com/fact/f2ed9a74-4d79-4d33-8870-5667ed458de3
History
- no predecessors — first report